NCT01411501

Brief Summary

A multi-center clinical trial done recently by us(NCT00508482) shows that needling on ST25 has the same effect as lactulose in unaided self-defecation frequency of a week and has better effect in symptoms improvement (in press). The object is to evaluate whether acupuncture is effective for functional constipation. As an explanatory research, it took one single point as its intervention and sham acupuncture as its control group (patients were blinded). On the basis of its confirmed effect, we are taking a pragmatic randomized controlled trial to further evaluate whether acupuncture is more effective than routine treatment. Acupuncture prescriptions used in this trial are individually prescribed according to syndrome differentiation, which can improve clinical effect. .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
684

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Sep 2011

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2011

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 8, 2011

Completed
24 days until next milestone

Study Start

First participant enrolled

September 1, 2011

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
1 year until next milestone

Results Posted

Study results publicly available

December 11, 2015

Completed
Last Updated

December 11, 2015

Status Verified

November 1, 2015

Enrollment Period

3.1 years

First QC Date

July 28, 2011

Results QC Date

September 25, 2015

Last Update Submit

November 8, 2015

Conditions

Keywords

AcupunctureFunctional constipation

Outcome Measures

Primary Outcomes (1)

  • Change of the SBMs From Baseline at Week 4

    \[average number of spontaneous bowel movements in a week at week 4\]-\[average number of spontaneous bowel movements in a week at baseline\]

    baseline and at 4 weeks

Secondary Outcomes (5)

  • Change From Baseline in the Bristol Stool Scale at the 4th Week

    baseline and at 4 weeks

  • Change From Baseline in Difficulty Degree of Defecation at the 4th Week

    baseline and at 4 weeks

  • Changes of the SBMs From Baseline at Week 8

    baseline and at 8 weeks

  • Change From Baseline in the Bristol Stool Scale at the 8th Week

    baseline and at 8 weeks

  • Change From Baseline in Difficulty Degree of Defecation at the 8th Week

    baseline and at 8 weeks

Study Arms (4)

Acupuncture at ST25 and BL25

EXPERIMENTAL

the points formula of back-shu point combination with front-mu point.

Other: acupuncture

Acupuncture at LI11 and ST37

EXPERIMENTAL

the points formula of He-points

Other: acupuncture

Acupuncture at ST25, BL25, LI11 and ST37

EXPERIMENTAL

the formula of He-point,back-shu point and front-mu point

Other: acupuncture

medicine

ACTIVE COMPARATOR

oral use of mosapride citrate

Drug: mosapride citrate

Interventions

Thrust and lift the needle to achieve De Qi. After being needled, the points will be punctured again using auxiliary needles 2 mm lateral to the first needle, and to a depth of 2 mm without manual stimulation. Put the electric stimulator on the pair of needles with a continuous wave, 20Hz. The current intensity is increased to the patients' maximum tolerance and then slightly reduced to a bearable level (0.1-1.0 mA). Huatuo Brand needle (φ0.30×25mm,φ0.30×40mm,φ0.30×50mm, produced by Suzhou Medical Appliance Factory) and G6805-1A electro-acupuncture apparatus(produced by Shanghai Huayi Medical Instrument Co. Ltd.) will be used. Five sessions/week in the first 2 weeks, three sessions/week for in the last 2 weeks.

Also known as: acupuncture and moxibustion
Acupuncture at LI11 and ST37Acupuncture at ST25 and BL25Acupuncture at ST25, BL25, LI11 and ST37

4-week oral use of mosapride citrate, 5mg, three times daily 0.5 hour before meal

Also known as: mosapride citrate,made in China
medicine

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who has been diagnosed with functional constipation according to Rome Ⅲ criteria
  • Patients who are aged 18-75 years old
  • Stop medication or acupuncture (if any) 1 week before randomization and uninvolved in other trials
  • Sign the informed consent out of one's own will

You may not qualify if:

  • Secondary constipation
  • Patients with consciousness impairment, psychotic patients or patients unable to express clearly
  • Patients with malignant tumor in progressive stage, severe wasting disease and liable to be infected and bleed
  • Patients with severe cardiovascular disease, hepatic injury, renal damage, digestive disease or hematological diseases
  • Women in pregnancy and lactation period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

No.5 Beixiange Street, Xuanwu District

Beijing, 100053, China

Location

Related Publications (1)

  • Li Y, Zheng H, Zeng F, Zhou SY, Zhong F, Zheng HB, Chen M, Jing XH, Cai YY, Jia BH, Zhu B, Liu ZS. Use acupuncture to treat functional constipation: study protocol for a randomized controlled trial. Trials. 2012 Jul 3;13:104. doi: 10.1186/1745-6215-13-104.

MeSH Terms

Conditions

Constipation

Interventions

Acupuncture TherapyMoxibustionmosapride

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Limitations and Caveats

Unblinding of participants in the acupuncture and mosapride groups;an insufficient duration to assess the long term effect or risks;a missing assessment of electrocardiograms for possible cardiovascular harm of mosapride

Results Point of Contact

Title
Liu Zhishun
Organization
Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences

Study Officials

  • LIU Zhishun, phD

    Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dean of Acupuncture Department of Guangan'men Hospital

Study Record Dates

First Submitted

July 28, 2011

First Posted

August 8, 2011

Study Start

September 1, 2011

Primary Completion

October 1, 2014

Study Completion

December 1, 2014

Last Updated

December 11, 2015

Results First Posted

December 11, 2015

Record last verified: 2015-11

Locations